Tessera Stock
HealthTechTessera is a pioneer in gene writing technology that is engineered to make minor and major modifications to the human genome permanently. Their technology equips scientists and clinicians with the capability to inscribe therapeutic messages, both small and large, into the genome to tackle diseases at their root. This empowers healthcare professionals to heal their patients and enhance their quality of life.
Abu Dhabi Investment Authority, Toba Capital, Flagship Pioneering, Foresite Capital Management, TA Ventures, Alaska Permanent Fund, Qatar Investment Authority, March Capital, T. Rowe Price, OMX Ventures, Altitude Life Science Ventures, SoftBank Investment Advisers, Salt Funds Management, Longevity Vision Fund, Hanwha Impact, EDBI, Cormorant Asset Management, ARTIS Ventures.